SCHEMBL7066564

SCHEMBL7066564

CCOC(Cc1ccccc1OCc1cnc2ccccc2c1)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.40
FCER2 P06734 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
PDE10A Q9Y233 10/20 0.40
SCN9A Q15858 1/20 0.38
NOTUM Q6P988 1/20 0.38
CGAS Q8N884 1/20 0.37
LMNA P02545 2/20 0.37
RAB9A P51151 2/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
FAAH O00519 1/20 0.37
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
TRPM5 Q9NZQ8 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069282 0.91 PPARG (0.45) PDE10ASCN9AHTTSMN1; SMN2
SCHEMBL7066781 0.90 CYP1A2 (0.42) PDE10ASCN9ANOTUMCGASLMNA
SCHEMBL7069421 0.89 SIRT2 (0.43) PDE10ASCN9ANOTUMLMNARAB9A
SCHEMBL7070263 0.86 SCN9A (0.38) PDE10ASCN9ANOTUMCGASFAAH
SCHEMBL7069687 0.85 PDE10A (0.39) PDE10ASCN9ATRPV1
SCHEMBL7066562 0.84 PPARA (0.53)
SCHEMBL7069482 0.83 MAOB (0.37) PDE10ASCN9ANOTUMCGASRAB9A
SCHEMBL7069697 0.83 PPARG (0.41) PDE10ASCN9ANOTUMHTTSMN1; SMN2
SCHEMBL7068772 0.82 PDE10A (0.42) PDE10ASCN9ANOTUMCGASLMNA
SCHEMBL7069548 0.81 PDE10A (0.42) PDE10ASCN9ANOTUMCGASLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA MMP1 3650/4885FCER2 3772/4885MMP3 4195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.